DRUG vs HPP-P-C

Comparison between Bright Minds Biosciences Inc (DRUG, Company) and Hudson Pacific Properties Inc (HPP-P-C, Company).

5-Year PerformanceDRUG has outperformed HPP-P-C, delivering a return of +28.2% compared to -3.3%

DRUG vs HPP-P-C - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	DRUG(COMPANY)	HPP-P-C(COMPANY)
Market Cap	$728M	$724M
Max Drawdown	97.68%	69.84%
Sharpe Ratio	1.76	0.20
5Y Beta	-0.81	0.39
Industry	Biotechnology	N/A
P/E Ratio	-30.85	-0.99
PEG Ratio	-0.08	N/A
5Y EPS CAGR	8.42%	N/A
Debt to Equity	0.03%	0.00%
Free Cash Flow Yield	-2.00%	16.71%
P/B Ratio	3.34	N/A

Market Cap

Winner

DRUG

$728M

HPP-P-C

$724M

Max Drawdown

DRUG

97.68%

Winner

HPP-P-C

69.84%

Sharpe Ratio

Winner

DRUG

1.76

HPP-P-C

0.20

5Y Beta

Winner

DRUG

-0.81

HPP-P-C

0.39

Industry

DRUG

Biotechnology

HPP-P-C

N/A

P/E Ratio

Winner

DRUG

-30.85

HPP-P-C

-0.99

PEG Ratio

DRUG

-0.08

HPP-P-C

N/A

5Y EPS CAGR

DRUG

8.42%

HPP-P-C

N/A

Debt to Equity

DRUG

0.03%

Winner

HPP-P-C

0.00%

Free Cash Flow Yield

DRUG

-2.00%

Winner

HPP-P-C

16.71%

P/B Ratio

DRUG

3.34

HPP-P-C

N/A

DRUG vs HPP-P-C - Historical Returns

Returns include dividend reinvestment.

Period	DRUG	HPP-P-C
1 month	+23.00%	-3.91%
3 months	-17.82%	+1.11%
6 months	-10.11%	-2.46%
1 year	+185.42%	+3.96%
5 years(CAGR)	+28.20%	-3.31%
Max(CAGR)	+21.02%	-3.31%

Winner

DRUG

+23.00%

HPP-P-C

-3.91%

DRUG

-17.82%

Winner

HPP-P-C

+1.11%

DRUG

-10.11%

Winner

HPP-P-C

-2.46%

Winner

DRUG

+185.42%

HPP-P-C

+3.96%

5Y(CAGR)

Winner

DRUG

+28.20%

HPP-P-C

-3.31%

Max(CAGR)

Winner

DRUG

+21.02%

HPP-P-C

-3.31%

DRUG vs HPP-P-C - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

Year	DRUG	HPP-P-C
2026	-10.60%	-2.85%
2025	+89.83%	+20.41%
2024	+1859.10%	+10.84%
2023	-63.33%	+18.76%
2022	-78.04%	-47.73%
2021	-41.30%	+5.54%

DRUG vs HPP-P-C Drawdown Comparison

The maximum drawdown for DRUG was -97.68%, occurring on Jul 11, 2024. Recovery took 740 trading sessions.

The maximum drawdown for HPP-P-C was -66.52%, occurring on May 12, 2023. This drawdown has not yet recovered.

The current DRUG drawdown is -22.27%. The current HPP-P-C drawdown is -19.09%.

Rank	DRUG	HPP-P-C
#1	-97.68% Nov 8, 2021 - Oct 18, 2024	-66.52% Dec 31, 2021 - May 12, 2023
#2	-58.28% Nov 6, 2024 - Sep 29, 2025	-0.89% Dec 22, 2021 - Dec 31, 2021
#3	-38.35% Jan 7, 2026 - Jun 15, 2026	-0.76% Nov 16, 2021 - Nov 24, 2021
#4	-27.84% Mar 22, 2021 - Aug 24, 2021	-0.55% Dec 2, 2021 - Dec 6, 2021
#5	-26.13% Oct 21, 2025 - Nov 28, 2025	-0.47% Dec 14, 2021 - Dec 21, 2021
#6	-19.30% Dec 16, 2025 - Jan 7, 2026	-0.44% Nov 24, 2021 - Nov 29, 2021
#7	-16.21% Sep 30, 2025 - Oct 9, 2025	-0.27% Dec 7, 2021 - Dec 9, 2021
#8	-14.42% Oct 11, 2021 - Nov 3, 2021	-0.24% Nov 29, 2021 - Dec 2, 2021
#9	-9.05% Oct 24, 2024 - Nov 4, 2024	-0.12% Dec 9, 2021 - Dec 13, 2021
#10	-7.65% Oct 14, 2025 - Oct 21, 2025	N/A
#11	-5.42% Dec 11, 2025 - Dec 16, 2025	N/A
#12	-4.62% Sep 24, 2021 - Sep 29, 2021	N/A
#13	-4.59% Dec 8, 2025 - Dec 10, 2025	N/A
#14	-4.38% Aug 24, 2021 - Sep 1, 2021	N/A
#15	-3.81% Sep 1, 2021 - Sep 17, 2021	N/A

Correlation

Correlation between DRUG and HPP-P-C is 0.49 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.49

-101